Montelukast does not appear to increase the risk for neuropsychiatric adverse events in children and adolescents, according to a study published in JAMA Pediatrics. Montelukast is a leukotriene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback